Fact CheckerSign in

NCT07807228Recruiting

Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment

Changes in Fungal Mycobiome, Bacterial Microbiome, and Abundance of Staphylococcus Species After Lebrikizumab Treatment - a Prospective Multicenter Observational Cohort Study

Source: ClinicalTrials.gov · Last updated 8 Sept 2026

Brief summary (registry, in English)

The goal of this observational study is to characterize the skin myco- and microbiome of patients with atopic dermatitis before and after initiation of treatment with lebrikizumab. The main questions it aims to answer are: Does the skin mycobiome change with treatment? Does the skin microbiome change with treatment? Does the abundance of Staphylococcus species change with treatment?

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
23 Jun 2026
Start date
Jun 2025
Primary completion date
Dec 2026
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
NCT number
NCT07807228

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From Jun 2025 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous treatment with lebrikizumab
  • Current treatment with other biologics or JAK-inhibitors

Other illness

  • Hypersensitivity to lebrikizumab or any of its constituents
  • Active helminth infection

Other

  • Pregnancy or breastfeeding

Who the study is looking for

  • Adults ≥18 years diagnosed with atopic dermatitis and initiating treatment with lebrikizumab

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dermatology Department Bispebjerg
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.